Trial intelligence / Profile preview

Aspirin for Immune Activation in HIV

NCT02155985Phase 2Completed

Start
Aug 2014
Primary completion
Jun 2015
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 2 trial of aspirin in human immunodeficiency virus type 1 infection (HIV-1). Started Aug 2014; status: completed.

02

Drugs

aspirin
03

Conditions

human immunodeficiency virus type 1 infection (HIV-1)

Beyond the preview

Go deeper on NCT02155985.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02155985.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call